Helixgate https://validator.w3.org/feed/docs/rss2.html Home Trump blasts ‘disloyal’ Sen. Cassidy while pushing challenger in Louisiana Republican primary Opinion: The cloudy truth about ‘blue zones’ Encoded’s gene therapy reduced seizures in Dravet syndrome Makary resigns; Biogen reports Alzheimer’s data; and more STAT+: FDA drug center head Tracy Beth Høeg leaves as agency faces leadership vacuum CDER chief Høeg expected to leave FDA, according to source RAGE Implicated in Worsening Breast Cancer Mortality with Age Interim CDER head Høeg is out days after Makary: report Biopharma M&A maintains strength even as large deals wane STAT+: Takeda will pay $13.6 million to settle allegations it paid kickbacks to doctors ASGCT Q1 Landscape Report Paints Positive Picture for Gene and RNA Therapy Using Digital Technologies to Enhance Patient Experience and Better Manage Supply Chain FDA hold puts Aardvark Prader-Willi drug in limbo Supreme Court preserves access to widely used abortion pill, while lawsuit plays out Candel reports prostate cancer drug’s long-term data ahead of FDA filing Opinion: First hantavirus, now Ebola: What two outbreaks reveal about global preparedness Employment and funding growth fell in 2025: California Life Sciences report Aardvark’s next move after clinical hold; Alumis’ verdict on Acelyrin asset Sun Pharma recalls cancer drug after finding glass particles in some vials STAT+: A political contest in the U.K. could shake up drug pricing Biogen’s Alzheimer’s results bolster tau theory—and Denali’s next gen candidate Implantable Living Materials Contain Infection-Sensing Bacteria That Release Therapeutics Makary’s departure and Cassidy’s tenuous Senate seat ASGCT 2026: Rare Instance of AAV Integration into Human Genome Linked to Brain Tumor This week in Drug Discovery (11 – 15 May)  Andrea Pfeifer ends 23-year reign at AC Immune; Acadia’s top R&D exec announces retirement #ASGCT26: A Zillow-like marketplace for abandoned gene therapies goes live DNA‑Guided CRISPR Suggests a New Direction for RNA Editing Why isn’t alcohol seen as a public health emergency? Opinion: Tributes to Craig Venter and the genomics race are missing something important Supreme Court preserves mail access for abortion pill Alumis pulls back from would-be rival to Amgen’s Tepezza after assessing prospects Aardvark to dig into phase 3 data early after FDA imposes hold PSA screening for prostate cancer reduces disease-specific deaths, new review shows Guide DNA — not RNA — expands the CRISPR toolkit Encoded’s gene therapy reduced seizures in Dravet syndrome ASGCT 2026: Beverly Davidson Offers Vehicle and Route for Huntington’s Disease Gene Therapy Molecular Anchors Help Tumor Therapies Stay Longer on Cancer Cells STAT investigates the epidemic killing 178,000 Americans a year ASGCT dispatch: In vivo CAR-T is everywhere, but still preclinical STAT+: CDC plans to transfer monkeys to nonprofit’s sanctuary as it seeks to reduce animal testing GPCRs, radiopharma and the rise of functional peptide screening M&A isn’t just for big pharma. Mid-size companies are stepping up deal hunts Chutes & Ladders—AC Immune CEO bids adieu Infinitopes appoints CSO to advance immuno-oncology pipeline  Future of Aardvark’s Prader-Willi drug in doubt as FDA slaps full hold on program Create Medicines raises $122M to bolster in vivo CAR-T therapies Drugmakers have to go through rigorous tests to get a lower tariff rate CREATE jumps into CAR T competition with $122M series B